GlassScriptPhysician profile
Ramon Caballero
NPI 1851480453
$1,679.05
in general payments reported to CMS, 2019-2025
14 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $264 · 2023: $147 · 2024: $87.22 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797 · Travel and Lodging: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.07 |
| Travel and Lodging | $214.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $399.57 | 2023-2025 | Urolift |
| Coloplast Corp | $386.52 | 2020-2025 | |
| Astellas Pharma US INC | $283.13 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.24 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $113.71 | 2019-2020 | |
| Allergan, INC. | $110.88 | 2019-2020 | |
| Boston Scientific Corporation | $74.05 | 2019-2024 | Spaceoar Vue System - 10ml |
| Ferring Pharmaceuticals INC. | $37.64 | 2019 | |
| Olympus America INC. | $33.20 | 2025 | Itind System |
| Medtronic USA, INC. | $30.80 | 2019-2020 | |
| Baxter Healthcare | $27.74 | 2023 | Tisseel |
| Sumitomo Pharma America, INC. | $15.97 | 2025 | Gemtesa |
| Avadel Specialty Pharmaceuticals, LLC | $13.56 | 2019 | |
| Pfizer INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Caballero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.